Brief: Lunai Bioworks Identifies Three Parkinson's Disease Subtypes
09/12/2025 12:47
Dec 9 (Reuters) - Lunai Bioworks Inc LNAI.O: LUNAI BIOWORKS INC - IDENTIFIES THREE PARKINSON'S DISEASE SUBTYPES LUNAI BIOWORKS INC - PRIORITIZED DRUG TARGETS IN $13 BILLION PARKINSON'S MARKET Source text: ID:nPn57V7QLa Further company coverage: LNAI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing